Over the last few years, we have been moving towards a profile that is much more international and formulation-driven.

Rx Healthcare of tomorrow will have brands registered in major markets of the world, and in most markets, promoted by a high quality field force. In India, we expect to retain our position of market leadership in our key therapy areas, and reach leadership in newer therapy areas that we entered. In key international markets across Asia, South East Asia, Russia, China, the Middle East, and Africa we would be a strong speciality company with prescription driven sales. With a strong network and established company equity, we would be an excellent partner for a company seeking to license out products across markets.

In the high value generic markets of the we expect to become a respected generic company, with a portfolio comprising both of complex and simple-to-file generics, building an edge with technology and the cost advantage of vertical integration.

In line with our vision to be significant global player by 2015. Rx Healthcare is fast emerging as a true Indian multinational. As part of our strategy, we have, joint ventures, strategic alliances, contract manufacturing, own marketing offices.

Besides a significant presence in the Americas, CIS Countries, Africa, Central and South-East Asia, Oceanic Countries, Japan, Middle East and Europe, the company has plans to have its offices in USA, Japan, Kenya, Nigeria, Russia, Kazakhstan and Ukraine. We plan to expand operations to more than 100 countries by 2015.